Largest Disease Modification Trial For Parkinson's Disease Completes Enrollment

... The largest clinical study to investigate disease modification in early Parkinson's disease (PD) has completed enrollment. The ADAGIO (Attenuation of Disease progression with AZILECT(R) GIven Once-daily) study is evaluating approximately 1,200 recently diagnosed patients worldwide to determine if treatment with once-daily AZILECT(R) (rasagiline tablets) can slow the progression of PD. [click link for full article] ...